Amelita A. Woodruff, MD

Dr. Berger is Associate Professor in the Johns Hopkins Division of General Internal Medicine and Core Faculty at the Johns Hopkins Berman Institute of Bioethics, with joint appointment in the Johns Hopkins Bloomberg School of Public Health. With an active practice in primary care internal medicine at Johns Hopkins, Dr. Berger focuses his clinical, educational, and research work, as well as his widely read publications for the lay public, on the ways in which shared decision making in the doctor-patient encounter might be in conflict with medical evidence and the political, social, and psychological realities of the patient.Dr. Berger teaches residents in their internal medicine clinic and medical students on the wards at Johns Hopkins Hospital, and is part of a Berman faculty team which teaches bioethics to residents in a number of Johns Hopkins specialty programs. He is also staff physician at the Esperanza Clinic Health Center, a free clinic serving undocumented Spanish-speaking immigrants.Dr. Berger is the author of two books for the lay public on doctor-patient communication and on patient preference in the context of medical evidence.

Dr. Jonathan M. Zenilman is a professor of medicine, at the Johns Hopkins University School of Medicine. He also has joint appointments in population family and reproductive health, international health, and epidemiology at the Johns Hopkins University Bloomberg School of Public Health.Dr. Zenilman is known internationally for his work in infectious disease epidemiology. Prior to coming to Johns Hopkins in 1989, he was a medical epidemiologist at the U.S. Centers for Disease Control (CDC) where he developed the National Gonococcal Isolate Surveillance Program (GISP). , which has operated continuously since 1987. He also coordinated and wrote the 1989 STD Treatment Guidelines and has continuously consulted with CDC since.In Baltimore, his activities have included directing the Baltimore City Health Department Sexually Transmitted Infection (STI) program and developing the Johns Hopkins Center for STI Prevention and Training. His research encompassed nearly all areas of STD behavioral science and clinical epidemiology, as well as extensive experience in conducting Phase 1 through Phase 3 clinical trials for drugs and vaccines. In addition to being a productive researcher and clinician, he has been active in health policy, has served as a Senior Medical Advisor for the Office of the Assistant Secretary for Planning and Evaluation (DHHS) 1995-1997, has testified before Congress and the Maryland legislature on infectious diseases related issues. He has been a technical consultant on numerous advisory committees for CDC, NIH, DoD, and the US Presidential Commission on Bioethical Issues and on numerous data safety monitoring committees for drugs and vaccines. From 2003 until 2019 he was chief of the Division of Infectious Diseases at Johns Hopkins Bayview Medical Center, where in 2003 he implemented major clinical and research programs in STIs, hospital epidemiology, antibiotic stewardship, and skin and soft tissue infections. Since April 2020, he served as the Chairperson of the independent Data Safety Monitoring Committee for the Pfizer COVID-19 vaccine program.Dr. Zenilman has >360 publications and is an active teacher, mentoring more than 50 fellows and residents during his career.

The Johns Hopkins Sidney Kimmel Cancer Center in Baltimore, MD is a renowned medical facility specializing in cancer treatment and research. With a focus on providing cutting-edge care and advancing scientific knowledge, the center is dedicated to improving outcomes for cancer patients through innovative therapies and personalized treatment plans. Generated from their business information